Abstract
Over the last decade and following technological advances, particularly in the high-throughput analysis of “omics,” the relationship between microbiota and the host has not yet been fully recognized and despite progress in the pathophysiological understanding of cardiometabolic diseases. These pathologies are still the first cause of mortality worldwide with a disease morbidity rate remaining unacceptably high. The link between intestinal microbiota and cardiometabolic risks is well extended and developed, unlike the role of the oral microbiota (2nd most important microbiota in the human body) and more precisely the dysbiosis of this microbiota causing these complications still remains, not fully defined. In this chapter, we will talk about the link between oral microbiota and cardiometabolic diseases, with a first part on the dysbiosis of the oral microbiota and in particular periodontal disease; a second mechanistic part of this dysbiosis contributing to these complications and finally a last part on potential prevention and treatment strategies (prebiotic, probiotics, etc.).
Sylvie Lê and Chiara Cecchin-Albertoni had contributed equality in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adda G, et al. Consensus report of the joint workshop of the Italian Society of Diabetology, Italian Society of Periodontology and Implantology, Italian Association of Clinical Diabetologists (SID-SIdP-AMD). Nutr Metab Cardiovasc Dis. 2021;31(9):2515–25. https://doi.org/10.1016/j.numecd.2021.03.015.
Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci Landmark. 2007;12(10):3965–74. https://doi.org/10.2741/2363.
Arzate H, Zeichner-David M, Mercado-Celis G. Cementum proteins: role in cementogenesis, biomineralization, periodontium formation and regeneration. Periodontol. 2015;67(1):211–33. https://doi.org/10.1111/prd.12062.
Baniulyte G, Piela K, Culshaw S. How strong is the link between periodontitis and stroke? Evid Based Dent. 2021;22(1):10–1. https://doi.org/10.1038/s41432-021-0161-7.
Bao L, et al. Oral microbiome and SARS-CoV-2: beware of lung co-infection. Front Microbiol. 2020;11:1840. https://doi.org/10.3389/fmicb.2020.01840.
Beikler T, Flemmig TF. Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures. Periodontol. 2011;55(1):87–103. https://doi.org/10.1111/j.1600-0757.2010.00360.x.
Berezow AB, Darveau RP. Microbial shift and periodontitis. Periodontology. 2011;55(1):36–47. https://doi.org/10.1111/j.1600-0757.2010.00350.x.
Blasco-Baque V, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut. 2017;66(5):872–85. https://doi.org/10.1136/gutjnl-2015-309897.
Campanella V, et al. Periodontitis and cerebrovascular disease: a new novel in medicine. J Biol Regul Homeostat Agents. 2019;33(3 Suppl 1):135–44. DENTAL SUPPLEMENT.
Cani PD, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–72. https://doi.org/10.2337/db06-1491.
Cardoso EM, Reis C, Manzanares-Céspedes MC. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgrad Med. 2018;130(1):98–104. https://doi.org/10.1080/00325481.2018.1396876.
Cekici A, et al. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol. 2014;64(1):57–80. https://doi.org/10.1111/prd.12002.
D’Aiuto F, et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diab Endocrinol. 2018;6(12):954–65. https://doi.org/10.1016/S2213-8587(18)30038-X.
El-Awady AR, et al. Dendritic cells a critical link to alveolar bone loss and systemic disease risk in periodontitis: immunotherapeutic implications. Periodontology 2000. 2022;89(1):41–50. https://doi.org/10.1111/prd.12428.
Garidou L, et al. The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease. Cell Metab. 2015;22(1):100–12. https://doi.org/10.1016/j.cmet.2015.06.001.
Global oral health status report: towards universal health coverage for oral health by 2030 (n.d.). https://www.who.int/publications-detail-redirect/9789240061484. Accessed 15 Jan 2023.
Graziani F, et al. A systematic review and meta-analysis of epidemiologic observational evidence on the effect of periodontitis on diabetes an update of the EFP-AAP review. J Clin Periodontol. 2018;45(2):167–87. https://doi.org/10.1111/jcpe.12837.
Hajishengallis G. Interconnection of periodontal disease and comorbidities: evidence, mechanisms, and implications. Periodontology 2000. 2022;89(1):9–18. https://doi.org/10.1111/prd.12430.
Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21(7):426–40. https://doi.org/10.1038/s41577-020-00488-6.
Hirose S, et al. Goblet cells are involved in translocation of staphylococcal enterotoxin A in the intestinal tissue of house musk shrew (Suncus murinus). J Appl Microbiol. 2016;120(3):781–9. https://doi.org/10.1111/jam.13029.
Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–85. https://doi.org/10.1038/nature21363.
Hug LA, et al. A new view of the tree of life. Nat Microbiol. 2016;1:16048. https://doi.org/10.1038/nmicrobiol.2016.48.
Jiang H, et al. Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis. Front Cardiovasc Med. 2022;9:925923. https://doi.org/10.3389/fcvm.2022.925923.
Khan MAB, et al. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Global Health. 2020;10(1):107–11. https://doi.org/10.2991/jegh.k.191028.001.
Kikui M, et al. Relationship between metabolic syndrome components and periodontal disease in a Japanese general population: the Suita study. J Atheroscler Thromb. 2017;24(5):495–507. https://doi.org/10.5551/jat.33761.
Kim CM, et al. Obesity and periodontitis: a systematic review and updated meta-analysis. Front Endocrinol. 2022;13:999455. https://doi.org/10.3389/fendo.2022.999455.
King S, Chow CK, Eberhard J. Oral health and cardiometabolic disease: understanding the relationship. Intern Med J. 2022;52(2):198–205. https://doi.org/10.1111/imj.15685.
Koren O, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108 Suppl 1(Suppl 1):4592–8. https://doi.org/10.1073/pnas.1011383107.
Lamster IB, Pagan M. Periodontal disease and the metabolic syndrome. Int Dent J. 2017;67(2):67–77. https://doi.org/10.1111/idj.12264.
Lee K, Kim J. Dairy food consumption is inversely associated with the prevalence of periodontal disease in Korean adults. Nutrients. 2019;11(5):1035. https://doi.org/10.3390/nu11051035.
Li J, et al. Identification of early microbial colonizers in human dental biofilm. J Appl Microbiol. 2004;97(6):1311–8. https://doi.org/10.1111/j.1365-2672.2004.02420.x.
Lopez-Neyman SM, et al. Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: NHANES 2011–2018. Sci Rep. 2022;12(1):19475. https://doi.org/10.1038/s41598-022-21878-x.
Louhelainen A-M, et al. Oral bacterial DNA findings in pericardial fluid. J Oral Microbiol. 2014;6:25835. https://doi.org/10.3402/jom.v6.25835.
Marsh PD, et al. Influence of saliva on the oral microbiota. Periodontol. 2016;70(1):80–92. https://doi.org/10.1111/prd.12098.
Matsha TE, et al. Oral microbiome signatures in diabetes mellitus and periodontal disease. J Dent Res. 2020;99(6):658–65. https://doi.org/10.1177/0022034520913818.
Mattila KJ, et al. Association between dental health and acute myocardial infarction. BMJ. 1989;298(6676):779–81. https://doi.org/10.1136/bmj.298.6676.779.
Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77(8):1289–303. https://doi.org/10.1902/jop.2006.050459.
Miele L, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49(6):1877–87. https://doi.org/10.1002/hep.22848.
Minty M, et al. Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases. Rev Endocr Metab Disord. 2019;20(4):449–59. https://doi.org/10.1007/s11154-019-09526-8.
Minty M, et al. Low-diversity microbiota in apical periodontitis and high blood pressure are signatures of the severity of apical lesions in humans. Int J Mol Sci. 2023;24(2):1589. https://doi.org/10.3390/ijms24021589.
Monsarrat P, et al. Clinical research activity in periodontal medicine: a systematic mapping of trial registers. J Clin Periodontol. 2016;43(5):390–400. https://doi.org/10.1111/jcpe.12534.
Moreno-Navarrete JM, et al. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia. 2013;56(11):2524–37. https://doi.org/10.1007/s00125-013-3015-9.
Mougeot J-LC, et al. Porphyromonas gingivalis is the most abundant species detected in coronary and femoral arteries. J Oral Microbiol. 2017;9(1):1281562. https://doi.org/10.1080/20002297.2017.1281562.
Moya-Pérez A, Neef A, Sanz Y. Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice. PLoS One. 2015;10(7):e0126976. https://doi.org/10.1371/journal.pone.0126976.
Muñoz Aguilera E, et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc Res. 2020;116(1):28–39. https://doi.org/10.1093/cvr/cvz201.
Musskopf ML, et al. Metabolic syndrome as a risk indicator for periodontal disease and tooth loss. Clin Oral Investig. 2017;21(2):675–83. https://doi.org/10.1007/s00784-016-1935-8.
Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontology. 2006;2000(40):11–28. https://doi.org/10.1111/j.1600-0757.2005.00141.x.
Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci. 2017;11(2):72–80.
Ngamdu KS, et al. Association between periodontal disease and cardiovascular disease (from the NHANES). Am J Cardiol. 2022;178:163–8. https://doi.org/10.1016/j.amjcard.2022.05.028.
Nunpan S, Suwannachart C, Wayakanon K. Effect of prebiotics-enhanced probiotics on the growth of Streptococcus mutans. Int J Microbiol. 2019;2019:4623807. https://doi.org/10.1155/2019/4623807.
Polak D, Shapira L. An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol. 2018;45(2):150–66. https://doi.org/10.1111/jcpe.12803.
Pussinen PJ, et al. Periodontitis and cardiometabolic disorders: the role of lipopolysaccharide and endotoxemia. Periodontology 2000. 2022;89(1):19–40. https://doi.org/10.1111/prd.12433.
Ruan Y, et al. Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: results from SAGE Wave 1. BMC Public Health. 2018;18:778. https://doi.org/10.1186/s12889-018-5653-9.
Sangwan A, et al. Effect of hyperlipidemia on response to nonsurgical periodontal therapy: statin users versus nonusers. Eur J Dentistry. 2016;10(1):69–76. https://doi.org/10.4103/1305-7456.175685.
Sanz M, Marco Del Castillo A, et al. Periodontitis and cardiovascular diseases: consensus report. J Clin Periodontol. 2020a;47(3):268–88. https://doi.org/10.1111/jcpe.13189.
Sanz M, Herrera D, et al. Treatment of stage I–III periodontitis – the EFP S3 level clinical practice guideline. J Clin Periodontol. 2020b;47(Suppl 22):4–60. https://doi.org/10.1111/jcpe.13290.
Scannapieco FA, Dongari-Bagtzoglou A. Dysbiosis revisited: understanding the role of the oral microbiome in the pathogenesis of gingivitis and periodontitis: a critical assessment. J Periodontol. 2021;92(8):1071–8. https://doi.org/10.1002/JPER.21-0120.
Schenkein HA. Host responses in maintaining periodontal health and determining periodontal disease. Periodontology. 2006;2000(40):77–93. https://doi.org/10.1111/j.1600-0757.2005.00144.x.
Sharma S, Tripathi P. Gut microbiome and type 2 diabetes: where we are and where to go? J Nutr Biochem. 2019;63:101–8. https://doi.org/10.1016/j.jnutbio.2018.10.003.
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–801. https://doi.org/10.1172/JCI29069.
Singh H, et al. Gastro-intestinal and oral microbiome signatures associated with healthy aging. GeroScience. 2019;41(6):907–21. https://doi.org/10.1007/s11357-019-00098-8.
Socransky SS, et al. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134–44. https://doi.org/10.1111/j.1600-051x.1998.tb02419.x.
Stöhr J, et al. Bidirectional association between periodontal disease and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Sci Rep. 2021;11(1):13686. https://doi.org/10.1038/s41598-021-93062-6.
Takeshita T, et al. Bacterial diversity in saliva and oral health-related conditions: the Hisayama Study. Sci Rep. 2016;6:22164. https://doi.org/10.1038/srep22164.
ten Cate JM. Biofilms, a new approach to the microbiology of dental plaque. Odontology. 2006;94(1):1–9. https://doi.org/10.1007/s10266-006-0063-3.
Thomas C, et al. Oral microbiota: a major player in the diagnosis of systemic diseases. Diagnostics (Basel). 2021;11(8):1376. https://doi.org/10.3390/diagnostics11081376.
Tiensripojamarn N, et al. Periodontitis is associated with cardiovascular diseases: a 13-year study. J Clin Periodontol. 2021;48(3):348–56. https://doi.org/10.1111/jcpe.13418.
Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018;200(4):525–40. https://doi.org/10.1007/s00203-018-1505-3.
Wang X, et al. Fungal biofilm inhibitors from a human oral microbiome-derived bacterium. Org Biomol Chem. 2012;10(10):2044–50. https://doi.org/10.1039/c2ob06856g.
Wu Y, et al. Effect of aging on periodontal inflammation, microbial colonization, and disease susceptibility. J Dental Res. 2016;95:460. https://doi.org/10.1177/0022034515625962.
Yang S, et al. Association between periodontitis and peripheral artery disease: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2018;18(1):141. https://doi.org/10.1186/s12872-018-0879-0.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 Springer Nature Switzerland AG
About this entry
Cite this entry
Lê, S. et al. (2024). The Other Microbiome: Oral Microbiota and Cardiometabolic Risk. In: Federici, M., Menghini, R. (eds) Gut Microbiome, Microbial Metabolites and Cardiometabolic Risk. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-031-35064-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-031-35064-1_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35063-4
Online ISBN: 978-3-031-35064-1
eBook Packages: MedicineReference Module Medicine